1 EXHIBIT 10.26 GENOME THERAPEUTICS CORP. REGISTRATION RIGHTS AGREEMENT This AGREEMENT (the "Agreement") is made as of March 20, 1995 by and among Genome Therapeutics Corp., a Massachusetts corporation (the "Company") and the persons whose names are...Registration Rights Agreement • November 29th, 1995 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Massachusetts
2- 3 conversion notice minus a number of shares equal to (x) the Warrant Price multiplied by (y) the number of shares designated in the conversion notice divided by (z) the Current Market Price.Genome Therapeutics Corp • November 29th, 1995 • In vitro & in vivo diagnostic substances
1 - 2 1.3. The Closing. Subject to the other terms and conditions of this Agreement, the purchase and sale of the Units (the "Closing") will take place on March 20, 1995, at 10:00 a.m. Boston time, at the offices of Ropes & Gray, One International...Stock and Warrant Purchase Agreement • November 29th, 1995 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Massachusetts
EXHIBIT 10.28 AGREEMENT28 Agreement • November 29th, 1995 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Massachusetts
